Luigi Mangione, the suspect accused in the December 2024 targeted killing of UnitedHealthcare CEO Brian Thompson, is expected to plead guilty in federal court, according to reports citing sources familiar with the matter. The last-minute development follows a joint request filed by federal prosecutors and Mangione’s defense team for an unexpected Friday hearing in Manhattan federal court.

The sudden scheduling fueled widespread expectation of a federal plea agreement, coming just weeks before Mangione was slated to stand trial on separate state murder charges in New York, where jury selection was set to begin on September 8. While details regarding the specific charges included in the expected plea agreement have not been formally released, legal analysts note that entering a federal guilty plea could carry significant procedural implications for the high-profile case.

Mangione's defense team may attempt to leverage the federal resolution to argue against state-level prosecution on double-jeopardy grounds, potentially aiming to consolidate the legal proceedings under federal jurisdiction. State prosecutors in Manhattan had previously signaled awareness of potential federal plea negotiations, warning that any agreement structured to bypass state-level accountability would face strong opposition from local officials and the victim's family.

As the court prepares for Friday's hearing, law enforcement agencies maintain that justice must be fully served for the violent execution of the healthcare executive.